Fervent Synergies Reports Negative Financial Performance in Q1 2024
Fervent Synergies, a microcap pharmaceutical company, has reported a negative financial performance for the quarter ending March 2024. The company's stock has been given a 'Strong Sell' rating by MarketsMojo due to a decline in its financial health. Factors such as a significant decrease in Profit Before Tax and Operating Profit contribute to this decline.
Fervent Synergies, a microcap pharmaceutical company, recently announced its financial results for the quarter ending March 2024. The company's stock has been given a 'Strong Sell' rating by MarketsMOJO.
According to the financial report, Fervent Synergies has seen a negative performance in the quarter, with a score of -9 compared to 7 in the previous quarter. This indicates a decline in the company's financial health.
One of the major factors contributing to this decline is the Profit Before Tax (PBT) less Other Income, which has fallen by -6144.4% to Rs -13.60 crore compared to the average PBT of the previous four quarters, which was Rs 0.23 crore. The Profit After Tax (PAT) has also seen a significant decrease of -9678.6% to Rs -13.41 crore compared to the average PAT of Rs 0.14 crore in the previous four quarters.
The company's Operating Profit (PBDIT) for the quarter was at its lowest in the last five quarters, at Rs -13.55 crore. This indicates a negative trend in the company's operating profit. Similarly, the PBT has also hit its lowest point in the last five quarters, at Rs -13.60 crore.
The Earnings per Share (EPS) for the quarter was also at its lowest in the last five quarters, at Rs -4.47. This shows a decline in profitability and a lower return for shareholders.
Overall, Fervent Synergies has reported a negative financial performance for the quarter ending March 2024. Investors should take note of these results and make informed decisions about their investments in the company.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
